{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:29:32Z","timestamp":1787236172539,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ymthe.2025.02.026","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T03:21:34Z","timestamp":1740021694000},"page":"1608-1620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["RESET: A TCR-coupled antigen receptor with superior targeting sensitivity and reversible drug-regulated anti-tumor activity"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8668-0569","authenticated-orcid":false,"given":"Jardin","family":"Leleux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olmo","family":"Sonzogni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Venkitaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Garrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Jarjour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.02.026_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101459","article-title":"Resistance against anti-CD19 and anti-BCMA CAR T\u00a0cells: Recent advances and coping strategies","volume":"22","author":"Atilla","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ymthe.2025.02.026_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/ejh.14101","article-title":"Antigen loss following CAR-T cell therapy: Mechanisms, implications, and potential solutions","volume":"112","author":"Mishra","year":"2024","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ymthe.2025.02.026_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11912-023-01380-x","article-title":"CAR-T Therapies in Solid Tumors: Opportunities and Challenges","volume":"25","author":"Guzman","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.ymthe.2025.02.026_bib4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.immuni.2013.08.036","article-title":"A Single Peptide-Major Histocompatibility Complex Ligand Triggers Digital Cytokine Secretion in CD4+ T Cells","volume":"39","author":"Huang","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.02.026_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ni.2190","article-title":"How the TCR balances sensitivity and specificity for the recognition of self and pathogens","volume":"13","author":"Morris","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.02.026_bib6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1074-7613(00)80483-5","article-title":"Evidence that a Single Peptide\u2013MHC Complex on a Target Cell Can Elicit a Cytolytic T Cell Response","volume":"4","author":"Sykulev","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2025.02.026_bib7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T Cell Activation","volume":"27","author":"Smith-Garvin","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.ymthe.2025.02.026_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.835762","article-title":"Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects","volume":"13","author":"Shafer","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.02.026_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2182058","article-title":"Mesothelin-targeting T\u00a0cells bearing a novel T\u00a0cell receptor fusion construct (TRuC) exhibit potent antitumor efficacy against solid tumors","volume":"12","author":"Ding","year":"2023","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ymthe.2025.02.026_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41417-021-00307-7","article-title":"TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential","volume":"28","author":"Poorebrahim","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ymthe.2025.02.026_bib11","article-title":"Sensitive and adaptable pharmacological control of CAR T\u00a0cells through extracellular receptor dimerization","volume":"5","author":"Leung","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2025.02.026_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb5191","article-title":"Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors","volume":"13","author":"Liu","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.02.026_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41591-021-01621-1","article-title":"HLA-independent T\u00a0cell receptors for targeting tumors with low antigen density","volume":"28","author":"Mansilla-Soto","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.02.026_bib14","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41467-019-10097-0","article-title":"Synthetic TRuC receptors engaging the complete T\u00a0cell receptor for potent anti-tumor response","volume":"10","author":"Baeuerle","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.02.026_bib15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41571-022-00704-3","article-title":"Overcoming on-target, off-tumour toxicity of CAR T\u00a0cell therapy for solid tumours","volume":"20","author":"Flugel","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2025.02.026_bib16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/mt.2010.24","article-title":"Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2","volume":"18","author":"Morgan","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.02.026_bib17","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00262-017-2034-7","article-title":"The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T\u00a0cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity","volume":"66","author":"Thistlethwaite","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ymthe.2025.02.026_bib18","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","article-title":"Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T\u00a0cells in myeloma and melanoma","volume":"122","author":"Linette","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.02.026_bib19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S1470-2045(21)00353-3","article-title":"CAR T-cell therapy for solid tumours","volume":"22","author":"Oncology","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ymthe.2025.02.026_bib20","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3389\/fimmu.2017.01603","article-title":"Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics","volume":"8","author":"Bannas","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2025.02.026_bib21","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1073\/pnas.94.15.7825","article-title":"Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen","volume":"94","author":"Liberles","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.02.026_bib22","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/nar\/gkt1224","article-title":"megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering","volume":"42","author":"Boissel","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2025.02.026_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162593","article-title":"Drug-regulated CD33-targeted CAR T\u00a0cells control AML using clinically optimized rapamycin dosing","volume":"134","author":"Appelbaum","year":"2024","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.02.026_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abe2606","article-title":"Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in\u00a0vivo function","volume":"14","author":"Salter","year":"2021","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ymthe.2025.02.026_bib25","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41423-020-0470-3","article-title":"Signaling from T\u00a0cell receptors (TCRs) and chimeric antigen receptors (CARs) on T\u00a0cells","volume":"17","author":"Wu","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ymthe.2025.02.026_bib26","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41591-023-02452-y","article-title":"Mesothelin-targeting T\u00a0cell receptor fusion construct cell therapy in refractory solid tumors: phase 1\/2 trial interim results","volume":"29","author":"Hassan","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.02.026_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","article-title":"Rapamycin: One Drug, Many Effects","volume":"19","author":"Li","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2025.02.026_bib28","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41590-020-0719-0","article-title":"Inefficient CAR-proximal signaling blunts antigen sensitivity","volume":"21","author":"Gudipati","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2025.02.026_bib29","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4049\/jimmunol.1402346","article-title":"Target Antigen Density Governs the Efficacy of Anti\u2013CD20-CD28-CD3 \u03b6 Chimeric Antigen Receptor\u2013Modified Effector CD8+ T Cells","volume":"194","author":"Watanabe","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2025.02.026_bib30","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.ymthe.2017.06.008","article-title":"Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase","volume":"25","author":"Walker","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.02.026_bib31","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1158\/1078-0432.CCR-14-2708","article-title":"A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response","volume":"21","author":"Robbins","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.02.026_bib32","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1158\/2326-6066.CIR-22-0040","article-title":"Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor\u2013Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors","volume":"10","author":"Kim","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ymthe.2025.02.026_bib33","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/1078-0432.CCR-13-3017","article-title":"Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma","volume":"20","author":"Chodon","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2025.02.026_bib34","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1182\/bloodadvances.2019000194","article-title":"Long-term safety and activity of NY-ESO-1 SPEAR T\u00a0cells after autologous stem cell transplant for\u00a0myeloma","volume":"3","author":"Stadtmauer","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2025.02.026_bib35","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.ymthe.2020.06.009","article-title":"A New Safety Approach Allowing Reversible Control of CAR T Cell Responses","volume":"28","author":"Chen","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.02.026_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.omto.2023.04.005","article-title":"Regulation of CD19 CAR-T cell activation based on an engineered downstream transcription factor","volume":"29","author":"Lain\u0161\u010dek","year":"2023","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.ymthe.2025.02.026_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba1786","article-title":"Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling","volume":"372","author":"Weber","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.02.026_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41586-023-05778-2","article-title":"Co-opting signalling molecules enables logic-gated control of CAR T\u00a0cells","volume":"615","author":"Tousley","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.02.026_bib39","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2216352120","article-title":"Inefficient exploitation of accessory receptors reduces the sensitivity of chimeric antigen receptors","volume":"120","author":"Burton","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.02.026_bib44","article-title":"Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets","volume":"11","author":"Laletin","year":"2023","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2025.02.026_bib45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","article-title":"T cell receptor (TCR) signaling in health and disease","volume":"6","author":"Shah","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.02.026_bib46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/hum.2018.001","article-title":"Effective Targeting of Multiple B-Cell Maturation Antigen-Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells","volume":"29","author":"Friedman","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.02.026_bib47","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/bioinformatics\/btm563","article-title":"Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R","volume":"24","author":"Langfelder","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2025.02.026_bib48","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1093\/nar\/gkx544","article-title":"Crystallographic analyses illustrate significant plasticity and efficient recoding of meganuclease target specificity","volume":"45","author":"Werther","year":"2017","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625001169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625001169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T20:44:23Z","timestamp":1751575463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625001169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1525001625001169"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.02.026","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RESET: A TCR-coupled antigen receptor with superior targeting sensitivity and reversible drug-regulated anti-tumor activity","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}